• Nikoloas Papachristou, Payam Barnaghi, Bruce A Cooper, Xiao Hu, Roma Maguire, Kathi Apostolidis, Jo Armes, Yvette P Conley, Marilyn Hammer, Stylianos Katsaragakis, Kord M Kober, Jon D Levine, Lisa McCann, Elisabeth Patiraki, Steven M Paul, Emma Ream, Fay Wright, and Christine Miaskowski.
• School of Health Sciences, University of Surrey, Guilford, UK.
• J Pain Symptom Manage. 2018 Feb 1; 55 (2): 318-333.e4.

ContextRisk profiling of oncology patients based on their symptom experience assists clinicians to provide more personalized symptom management interventions. Recent findings suggest that oncology patients with distinct symptom profiles can be identified using a variety of analytic methods.ObjectivesThe objective of this study was to evaluate the concordance between the number and types of subgroups of patients with distinct symptom profiles using latent class analysis and K-modes analysis.MethodsUsing data on the occurrence of 25 symptoms from the Memorial Symptom Assessment Scale, that 1329 patients completed prior to their next dose of chemotherapy (CTX), Cohen's kappa coefficient was used to evaluate for concordance between the two analytic methods. For both latent class analysis and K-modes, differences among the subgroups in demographic, clinical, and symptom characteristics, as well as quality of life outcomes were determined using parametric and nonparametric statistics.ResultsUsing both analytic methods, four subgroups of patients with distinct symptom profiles were identified (i.e., all low, moderate physical and lower psychological, moderate physical and higher Psychological, and all high). The percent agreement between the two methods was 75.32%, which suggests a moderate level of agreement. In both analyses, patients in the all high group were significantly younger and had a higher comorbidity profile, worse Memorial Symptom Assessment Scale subscale scores, and poorer QOL outcomes.ConclusionBoth analytic methods can be used to identify subgroups of oncology patients with distinct symptom profiles. Additional research is needed to determine which analytic methods and which dimension of the symptom experience provide the most sensitive and specific risk profiles.Copyright © 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

28 keywords...

hide…